Bortezomib synergizes TRAIL-induced apoptosis in gastric cancer cells

Digestive Diseases and Sciences

Volumn 55, Issue 12, 2010, Pages 3361-3368

  Liu, Jing ^a   Qu, Xiu Juan ^a   Xu, Ling ^a   Zang, Ye ^a   Qu, Jing Lei ^a   Hou, Ke Zuo ^a   Liu, Yun Peng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bortezomib; CIAP 1; Death receptor; Gastric cancer; TRAIL

Indexed keywords

BORTEZOMIB; DEATH RECEPTOR 4; DEATH RECEPTOR 5; INHIBITOR OF APOPTOSIS PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; STOMACH CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BORONIC ACIDS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SYNERGISM; HUMANS; PYRAZINES; STOMACH NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 78649317782     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1191-8     Document Type: Article

References (31)

1. JA Ajani RJ Mayer DM Ota, et al. 1993 Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma J Natl Cancer Inst 85 1839 1844 1:STN:280:DyaK2c%2FkslWgtA%3D%3D 10.1093/jnci/85.22. 1839 8230264
2. SR Wiley K Schooley PJ Smolak, et al. 1995 Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 673 682 1:CAS:528:DyaK28XhtF2iug%3D%3D 10.1016/1074-7613(95)90057-8 8777713
3. H Walczak RE Miller K Ariail, et al. 1999 Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat Med 5 157 163 1:CAS:528:DyaK1MXntlSrug%3D%3D 10.1038/5517 9930862
4. A Ashkenazi RC Pai S Fong, et al. 1999 Safety and antitumor activity of recombinant soluble Apo2 ligand J Clin Invest 104 155 162 1:CAS:528: DyaK1MXkslSmsbw%3D 10.1172/JCI6926 10411544
5. P Wang J Zhang A Bellail, et al. 2007 Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells Cell Signal 19 2237 2246 1:CAS:528:DC%2BD2sXhtVWmtb3L 10.1016/j.cellsig.2007.06.001 17693058
6. JH Song MC Tse A Bellail, et al. 2007 Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand-induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells Cancer Res 67 6946 6955 1:CAS:528:DC%2BD2sXnslOitrY%3D 10.1158/0008-5472.CAN-06-3896 17638906
7. AV Franco XD Zhang E Van Berkel, et al. 2001 The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells J Immunol 166 5337 5345 1:CAS:528:DC%2BD3MXjtFyrt7g%3D 11313369
8. W Chen X Wang J Zhuang L Zhang Y Lin 2007 Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells Carcinogenesis 28 2114 2121 1:CAS:528:DC%2BD2sXhtFeqsL7E 10.1093/carcin/bgm133 17548900
9. FH Psahoulia KG Drosopoulos L Doubravska L Andera A Pintzas 2007 Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts Mol Cancer Ther 6 2591 2599 1:CAS:528:DC%2BD2sXhtVCgur%2FL 10.1158/1535-7163.MCT-07-0001 17876056
10. A Mühlethaler-Mottet KB Bourloud K Auderset JM Joseph N Gross 2004 Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP Oncogene 23 5415 5425 10.1038/sj.onc.1207704 15094781
11. SY Nam GA Jung GC Hur, et al. 2003 Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers Cancer Sci 94 1066 1073 1:CAS:528:DC%2BD2cXhtlSrur0%3D 10.1111/j.1349-7006.2003.tb01402.x 14662022
12. J Sterz I von Metzler JC Hahne, et al. 2008 The potential of proteasome inhibitors in cancer therapy Expert Opin Investig Drugs 17 879 895 1:CAS:528:DC%2BD1cXmtV2ktrc%3D 10.1517/13543784.17.6.879 18491989
13. X Liu P Yue S Chen, et al. 2007 The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells Cancer Res 67 4981 4988 1:CAS:528:DC%2BD2sXltl2gtr8%3D 10.1158/0008-5472.CAN-06-4274 17510429
14. E Saulle A Petronelli L Pasquini, et al. 2007 Proteasome inhibitors sensitize ovarian cancer cells to TRAIL-induced apoptosis Apoptosis 12 635 655 1:CAS:528:DC%2BD2sXivVShtLg%3D 10.1007/s10495-006-0025-9 17252198
15. J Bai J Sui A Demirjian CM Vollmer Jr W Marasco MP Callery 2005 Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro Cancer Res 65 2344 2352 1:CAS:528:DC%2BD2MXisFGns74%3D 10.1158/0008-5472.CAN-04-3502 15781649
16. T Hasegawa K Suzuki C Sakamoto, et al. 2003 Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia Blood 101 1164 1171 1:CAS:528:DC%2BD3sXptVChsQ%3D%3D 10.1182/blood-2002-05-1505 12393423
17. CM Van Geelen EG de Vries S de Jong 2004 Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy Drug Resist Updat 7 345 358 10.1016/j.drup.2004.11.002 15790545
18. K Ishiguro T Ando O Maeda, et al. 2007 Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms Biochem Biophys Res Commun 362 218 223 1:CAS:528:DC%2BD2sXpsFKks7k%3D 10.1016/j.bbrc.2007.08.012 17706603
19. AA Chaudhari JW Seol SJ Kim, et al. 2007 Reactive oxygen species regulate Bax translocation and mitochondrial transmembrane potential, a possible mechanism for enhanced TRAIL-induced apoptosis by CCCP Oncol Rep 18 71 76 1:CAS:528:DC%2BD2sXot1Kmu7g%3D 17549348
20. CY Jin C Park J Cheong, et al. 2007 Genistein sensitizes TRAIL-resistant human gastric adenocarcinoma AGS cells through activation of caspase-3 Cancer Lett 257 56 64 1:CAS:528:DC%2BD2sXhtFSnt7vK 10.1016/j.canlet.2007.06.019 17689858
21. L Xu X Qu Y Zhang, et al. 2009 Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts FEBS Lett 583 943 948 1:CAS:528:DC%2BD1MXis1aqtbc%3D 10.1016/j.febslet.2009.02.014 19223002
22. P Balsas N López-Royuela P Galán-Malo A Anel I Marzo J Naval 2009 Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis Biochem Pharmacol 77 804 812 1:CAS:528:DC%2BD1MXitVOmurk%3D 10.1016/j.bcp.2008.11.024 19100720
23. S Wang WS El-Deiry 2003 TRAIL and apoptosis induction by TNF-family death receptors Oncogene 22 8628 8633 1:CAS:528:DC%2BD3sXptFOmur4%3D 10.1038/sj.onc.1207232 14634624
24. EK Rowinsky 2005 Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents J Clin Oncol 23 9394 9407 1:CAS:528: DC%2BD28Xnt1ymtw%3D%3D 10.1200/JCO.2005.02.2889 16361639
25. C Conticello L Adamo R Giuffrida, et al. 2007 Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death J Clin Endocrinol Metab 92 1938 1942 1:CAS:528:DC%2BD2sXlt1OkurY%3D 10.1210/jc.2006-2157 17327374
26. M Nikrad T Johnson H Puthalalath L Coultas J Adams AS Kraft 2005 The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim Mol Cancer Ther 4 443 449 1:CAS:528:DC%2BD2MXit1Knsrs%3D 15767553
27. H Zhu W Guo L Zhang, et al. 2005 Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation Cancer Biol Ther 4 781 786 1:CAS:528:DC%2BD28XjtlWktbs%3D 10.1158/1535-7163.MCT-04-0330 16082182
28. T Hideshima L Catley N Raje, et al. 2007 Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells Br J Haematol 138 783 791 1:CAS:528:DC%2BD2sXhtFCks77I 10.1111/j.1365-2141.2007.06714.x 17760810
29. F Li G Ambrosini EY Chu, et al. 1998 Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 580 584 1:CAS:528:DyaK1cXotVWns70%3D 10.1038/25141 9859993
30. AC Mita MM Mita ST Nawrocki FJ Giles 2008 Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics Clin Cancer Res 14 5000 5005 1:CAS:528:DC%2BD1cXpslKgsbs%3D 10.1158/1078-0432.CCR-08-0746 18698017
31. Y Dai TS Lawrence L Xu 2009 Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B Am J Transl Res 1 1 15 1:CAS:528:DC%2BD1MXhtFejs7vF 19966933